Skip to main content
Caplight Logo









GlycoDisplay ApS

GlycoDisplay ApS

Private
CopenhagenHealthcare & Life Scienceshttp://glycodisplay.com/

Last Round

Seed

Nov 30, 2016

Company Overview

GlycoDisplay ApS operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Seed round in November 2016.

GlycoDisplay ApS is a biotechnology company that develops novel biopharmaceuticals by modifying sugars using proprietary targeted cell engineering technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

GlycoDisplay ApS Comparables

Compare GlycoDisplay ApS with similar companies based on industry and business-model similarity.

GlycoDisplay ApS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GlyTech, Inc.
84%
CD BioGlyco
83%
GlycoT Therapeutics
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

GlycoDisplay ApS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 30, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 31% MoM.

  • Apr 7, 2026

    Monthly visitors increased 57% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

GlycoDisplay ApS Filings

Explore SEC and related filing metadata, where available.

GlycoDisplay ApS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about GlycoDisplay ApS's valuation, stock price, and market status.

Is GlycoDisplay ApS a public or private company?

GlycoDisplay ApS is a private company.

What is the current stock price of GlycoDisplay ApS?

GlycoDisplay ApS is a private company, so its shares have no public market price. Caplight tracks GlycoDisplay ApS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is GlycoDisplay ApS worth (valuation)?

Valuation information for GlycoDisplay ApS is not publicly available.

Can I buy GlycoDisplay ApS stock?

GlycoDisplay ApS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was GlycoDisplay ApS's last funding round?

GlycoDisplay ApS's most recent funding round was Seed on November 30, 2016.

Who are the main investors in GlycoDisplay ApS?

Investor information for GlycoDisplay ApS is not publicly disclosed.

Will GlycoDisplay ApS IPO soon?

No public IPO plans have been announced for GlycoDisplay ApS.

How can I track GlycoDisplay ApS secondary market activity?

Caplight tracks bids, offers, and trades in GlycoDisplay ApS's shares on secondary markets.

Firmographic Details

HeadquartersCopenhagen
Employee Range1
Year Founded2016
Last FundingNov 30, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?